12-45050744-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004329.3(DBX2):āc.184C>Gā(p.Pro62Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000274 in 1,496,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004329.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DBX2 | NM_001004329.3 | c.184C>G | p.Pro62Ala | missense_variant | 1/4 | ENST00000332700.6 | NP_001004329.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DBX2 | ENST00000332700.6 | c.184C>G | p.Pro62Ala | missense_variant | 1/4 | 2 | NM_001004329.3 | ENSP00000331470.6 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000213 AC: 2AN: 93684Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 52862
GnomAD4 exome AF: 0.0000178 AC: 24AN: 1344858Hom.: 0 Cov.: 32 AF XY: 0.0000121 AC XY: 8AN XY: 663068
GnomAD4 genome AF: 0.000112 AC: 17AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74280
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.184C>G (p.P62A) alteration is located in exon 1 (coding exon 1) of the DBX2 gene. This alteration results from a C to G substitution at nucleotide position 184, causing the proline (P) at amino acid position 62 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at